قياسات تشتت رامان المعززة بالسطح أحادية الجزيء التي تم تمكينها بواسطة الهوائيات النانوية لأوريغامي الحمض النووي البلازموني

Executive Industry Relevance

Single-molecule SERS enabled by plasmonic DNA origami nanoantennas provides unprecedented chemical specificity at the individual molecule level, addressing a critical gap in mechanistic de-risking and target validation for biopharma R&D. This capability allows for real-time tracking of molecular behavior and reactions, supporting predictive confidence in early discovery and translational research. The approach enhances portfolio decision-making by revealing molecular heterogeneity and reaction mechanisms that remain hidden in bulk analyses.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables direct interrogation of molecular mechanisms and reaction pathways at single-molecule resolution.
• Supports functional target validation by revealing heterogeneity and rare molecular events.
• Improves predictive confidence for target selection and mechanistic de-risking.

Screening & Assay Development

• Facilitates preparation of validated nanoscale systems for downstream single-molecule assays.
• Enables reproducible placement of analytes in SERS hotspots for quantitative readouts.
• Supports assay standardization and scalability for high-sensitivity compound evaluation.

Translational & Preclinical Research

• Allows detection of medically relevant biomolecules with high sensitivity at the single-molecule level.
• Provides continuity from discovery to preclinical validation by tracking molecular responses to environmental changes.
• Enables risk-adjusted advancement decisions based on detailed mechanistic insights.

Pipeline & Workflow Integration

This method integrates into the discovery continuum from early mechanistic studies through lead identification and translational research, providing a reusable platform for single-molecule analytics.

• Discovery Biology: Supports hypothesis testing and pathway clarification by enabling detection of individual molecular events.
• Screening: Delivers quantitative, reproducible SERS outputs for reliable comparison of analyte conditions.
• Analytics: Provides high-sensitivity spectroscopic readouts and AFM correlation for robust data interpretation.
• Translational Research: Aligns with biomarker detection and mechanistic studies relevant to disease models.
• Enterprise Reuse: Offers a standardized, scalable platform for diverse molecular targets and applications.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
• Operational Value: Delivers reproducible, standardized single-molecule measurements with scalable throughput.
• Strategic Value: Enables informed go/no-go decisions and reduces late-stage biological risk.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of high-value targets.

Implementation Considerations

• Requires expertise in DNA nanotechnology, AFM, and Raman spectroscopy.
• Needs access to advanced instrumentation for AFM imaging and SERS measurements.
• Demands rigorous cross-team standardization for reproducible nanoantenna assembly and data correlation.
• Adaptation across different analytes or biomolecules may require protocol optimization.
• Signal-to-noise ratio and hotspot reproducibility are practical considerations for robust implementation.

Biopharma FAQs